Company profilePharmaceutical#21 of 1,318 in Pakistan1 DRAP alert

SEARLE PAKISTAN (PVT.) LTD.

Pharmaceutical company · 339 brands · 415 molecules

Ranked #1 of 100 companies in Gastro

339 registered products 79 pharmaceutical brands 415 distinct molecules 1 DRAP alert

Company overview

339
registered products
79
pharmaceutical brands
415
distinct molecules
12
therapeutic classes
1
DRAP alerts

SEARLE PAKISTAN (PVT.) LTD. is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 339 product registrations across 415 distinct molecules. It is the 21st largest registrant in Pakistan by product count, and ranks 1st of 100 in Gastro. Its portfolio is concentrated in Gastro and Cardiac Care. DRAP has issued 1 alert involving its products.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Products by SEARLE

485 products matched in our catalogue · showing 80 — each with its observed price and DRAP approved ceiling.

Price ceiling age

DRAP sets a maximum price per registration and revises it only on application. In a market with high inflation, an old ceiling erodes margin in real terms.

270
ceilings with an approval date
0
not revised in 2+ years
2025
oldest approval year
20255
2026265

Top molecules by brand count

Nutritional Supplement / Multivitamin14 brands
Paracetamol14 brands
Amlodipine7 brands
Orphenadrine6 brands
Simvastatin6 brands
Metformin6 brands
Azithromycin6 brands
Sodium5 brands

Therapeutic classes

Gastro · 21Cardiac Care · 19Anti-Infectives · 17Pain Management · 11Drugs For Peptic Ulcer And Gastro-Oesophageal Reflux Disease (Gord) · 10Neuro · 10Other Beta-Lactam, Cephalosporins & Penems · 9Angiotensin-Ii Antagonists, Combinations · 9Blood Glucose Lowering Drugs, Excluding Insulin · 8Antiinflammatory And Antirheumatic Products · 7Opioids · 7Lipid Modifying Agents · 7

Conditions treated

General Infections · 17Hypertension · 10Ors · 6Pain Killers · 6Ulcer/Reflux/Flatulence/Acidity · 5Vomiting/Emesis · 4Oral Agents · 4High Cholestrol · 4Hormonal Therapy · 3Anxiety/Depression/Insomnia · 3Cold/Cough/Flu · 3Probiotic · 3

Price band (DRAP official ceilings)

Registered products priced by source
DRAP-official204 products · Rs 10.54 – Rs 169,475.13
DVAGO109 products · Rs 19 – Rs 3,705
Servaid195 products · Rs 18 – Rs 3,666
Median across source: Rs 304.51

Regulatory record

1 alert in the DRAP feed we track.

131. Recall Alert (Class-II) – DTLs Punjab Declared Substandard products.
2026-01-14

Competitive set

Companies whose registered portfolio overlaps most with this one.

Portfolio whitespace

Molecules the closest competitors have registered and this company has not — the starting point for a launch shortlist.

GETZ PHARMA PAKISTAN (PVT) LTD. holds 163 molecules not in this portfolio
),Formoterol3 ) 20Mg} Folic AcidAcyclovirAdrenalineAlbendazoleAmlodipne
BIO LABS (PVT) LTD. holds 80 molecules not in this portfolio
000 I.UAprepitantAremetherArtesunateAzathioprineAzithromycin 250Mg
MACTER INTERNATIONAL (PVT) LTD. holds 98 molecules not in this portfolio
000 I.U10Ug Polysaccharides Covalently Bound To 20Ug To 32Ug Of Tetanus ToxoidAlbendazoleAlbuterolAlfacalcidolAluminium Hydroxide

Get the full profile for SEARLE

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included

Company data as of 2026-07-30. Brand and molecule counts from the DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.